In chronic myelogenous leukemia (CML), the loss of SMO impaired the self-renewal capacity of the hematopoietic stem cells and hindered the initiation of CML by the oncoprotein: BCR-ABL1 [195]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.